Drug Type Unknown |
Synonyms TLN-254 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Treeline Biosciences, Inc.Startup |
Active Organization Treeline Biosciences, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
T-Cell Lymphoma | Phase 1 | US | Treeline Biosciences, Inc.Startup | 16 Dec 2024 |